Wuhan Tongyu Technology Co., Ltd. is a high-tech enterprise specialized in the research, development, production and sales of steroid biomedical products. The company is located in Wuhan, the central city of central China and the core of the Yangtze River Economic Belt - Jiangxia Optics Valley Nanda Health Industrial Park.

The R&D team of the company has completed the research on the new synthesis method of plant cholesterol after three years. With plant extracts as the starting material, it applied for independent invention patents. The plant-derived cholesterol production line built according to the requirements of modern biosynthesis technology has been put into production in batches at the base of Wuhan Optics Valley Nanda Health Industrial Park, with excellent and stable product quality. Non-animal source, no genetic risk and risk of carrying animal virus. It is very suitable for the application of lipid nanoparticles (LNP) delivery system, and is widely used in modern medicine fields such as nucleic acid drugs, mRNA vaccines and non-animal-derived cell culture media of protein drugs. It is also the main raw material for the synthesis of biogenic vitamin D3 and steroid hormones.

The company's quality policy: leading technology, high quality and efficiency, environmental protection, compliance and continuous improvement